Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Lublin – page 65

814 clinical trials in Lublin, Poland across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Lublin at a glance
814
clinical trials
  • Research sites7
Type of trial
Recruitment status
Quick filters

814 trials in Lublin

Open in trial search

Study on the Safety and Effectiveness of TP-102 for Treating Diabetic Foot Infections in Patients

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:F1245/05
  • Sponsor:Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.

Renal cell carcinoma

Not recruiting

Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Obesity+1

Not recruiting

Study Comparing Tirzepatide and Semaglutide for Weight Loss in Adults with Obesity or Overweight and Related Health Issues

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3298176
  • Sponsor:Eli Lilly & Co.

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Incyte Corp.

Partial seizures

Not recruiting

Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:Equilibre Biopharmaceuticals B.V.

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Systemic mastocytosis

Not recruiting

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
  • Sponsor:Cogent Biosciences Inc.

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

Embolism

Not recruiting

Study on REGN9933 for Preventing Blood Clots in Adults After Knee Replacement Surgery

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Macular oedema

Not recruiting

Study on the Effects of RO7200220 for Adults and Children with Uveitic Macular Edema

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Humanised IgG2 monoclonal antibody against INTERLEUKIN-6
  • Sponsor:F. Hoffmann-La Roche AG

Partial seizures

Not recruiting

Study on the Effects of Azetukalner in Reducing Focal-Onset Seizures for Patients with Epilepsy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Lublin

What the registry says about research in the country

01 Respiratory Health Research

Innovative clinical trials focusing on respiratory viral infections and preventive vaccines. Studies include investigations of RSV, human metapneumovirus, and influenza vaccines for older adults, alongside research on pneumococcal infections in children.

  • RSV and hMPV Prevention
  • Influenza Vaccine Development
  • COPD Treatment Studies

Current research emphasizes vaccine efficacy and immune response in vulnerable populations.

02 Dermatological Studies

Comprehensive research into dermatological conditions, with particular focus on psoriasis treatments. Multiple trials evaluating new therapeutic approaches for plaque psoriasis and genital psoriasis.

  • Plaque Psoriasis Treatments
  • Genital Psoriasis Therapy
  • Lichen Sclerosus Studies

Emphasis on developing targeted therapies for moderate to severe cases.

03 Chronic Disease Management

Advanced research into various chronic conditions, including Parkinson's disease, inflammatory bowel diseases, and cardiovascular conditions. Studies focus on innovative treatments and disease management approaches.

  • Heart Failure Prevention
  • Autoimmune Conditions
  • Neurological Disorders

Trials aim to improve patient outcomes through novel therapeutic interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.